Skip to content
The Monkeypox Vaccine Monopoly episode artwork

Aug 7, 2022 24 min

The Monkeypox Vaccine Monopoly

from What Next: TBD | Tech, power, and the future

It makes intuitive sense for companies that develop a technology to hold its intellectual property rights. But in the case of vaccines and medical treatments, IP laws slow down manufacturing and distribution and give private companies the power to make huge decisions that affect public health globally. Guest: Zain Rizvi, researcher for advocacy group Public Citizen, specializing in pharmaceutical innovation and access to medicine. Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

The Monkeypox Vaccine Monopoly

0:00 24:15

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of What Next: TBD | Tech, power, and the future?

This episode is 24 minutes long.

When was this What Next: TBD | Tech, power, and the future episode published?

This episode was published on August 7, 2022.

Can I download this What Next: TBD | Tech, power, and the future episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.